Tags

Type your tag names separated by a space and hit enter

RETRACTED ARTICLE

Intragastric balloon: another option for treatment of obesity and morbid obesity.
Hepatogastroenterology. 2004 Jan-Feb; 51(55):294-7.H

Abstract

BACKGROUND/AIMS

The BioEnterics Intragrastric Balloon (BIB, BioEnterics, Santa Barbara, CA) in association with restricted diet has been used for the treatment of obesity and morbid obesity.

METHODOLOGY

Since March 1998, 349 BIB were placed in 303 obese and morbidly obese patients; 95 patients were male and 208 female; mean age was 41.5 years (19-70); mean weight was 118.8 Kg (67-229); mean BMI was 42 Kg/m2, % excess weight was 62.3% (4.6-216.3). The balloon was inserted and removed endoscopically under general anesthesia. Patients were given a balanced diet of 1000 Kcal/day.

RESULTS

After 4 months of balloon treatment, the mean weight loss was 13.9 Kg and the mean reduction in BMI was 4.8 Kg/m2. Weight loss was greater in male patients. Weight loss was accompanied by an improvement of the diseases associated with obesity, in particular diabetes.

CONCLUSIONS

The best indications for BIB were: morbidly obese (BMI >40) and super-obese patients (BMI >50) in preparation for bariatric operations; obese patients with BMI 35-40 with co-morbidity in preparation for bariatric surgery; obese patients with BMI 30-35 with a chronic disease otherwise unresolved; patients with BMI <30 only in a multidisciplinary approach.

Authors+Show Affiliations

Dipartimento di Scienze Chirurgiche dell'Universita degli Studi di Milano-Divisione di Chirurgia, Istituto Clinico Sant'Ambrogio di Milano, Centro per la Farmacoterapia delle malattie nutrizionali e metaboliche, Italy. santo.bressani@unimi.itNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Retracted Publication

Language

eng

PubMed ID

15025034

Citation

Doldi, S B., et al. "Intragastric Balloon: Another Option for Treatment of Obesity and Morbid Obesity." Hepato-gastroenterology, vol. 51, no. 55, 2004, pp. 294-7.
Doldi SB, Micheletto G, Perrini MN, et al. Intragastric balloon: another option for treatment of obesity and morbid obesity. Hepatogastroenterology. 2004;51(55):294-7.
Doldi, S. B., Micheletto, G., Perrini, M. N., & Rapetti, R. (2004). Intragastric balloon: another option for treatment of obesity and morbid obesity. Hepato-gastroenterology, 51(55), 294-7.
Doldi SB, et al. Intragastric Balloon: Another Option for Treatment of Obesity and Morbid Obesity. Hepatogastroenterology. 2004;51(55):294-7. PubMed PMID: 15025034.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Intragastric balloon: another option for treatment of obesity and morbid obesity. AU - Doldi,S B, AU - Micheletto,G, AU - Perrini,M N, AU - Rapetti,R, PY - 2004/3/18/pubmed PY - 2004/6/21/medline PY - 2004/3/18/entrez SP - 294 EP - 7 JF - Hepato-gastroenterology JO - Hepatogastroenterology VL - 51 IS - 55 N2 - BACKGROUND/AIMS: The BioEnterics Intragrastric Balloon (BIB, BioEnterics, Santa Barbara, CA) in association with restricted diet has been used for the treatment of obesity and morbid obesity. METHODOLOGY: Since March 1998, 349 BIB were placed in 303 obese and morbidly obese patients; 95 patients were male and 208 female; mean age was 41.5 years (19-70); mean weight was 118.8 Kg (67-229); mean BMI was 42 Kg/m2, % excess weight was 62.3% (4.6-216.3). The balloon was inserted and removed endoscopically under general anesthesia. Patients were given a balanced diet of 1000 Kcal/day. RESULTS: After 4 months of balloon treatment, the mean weight loss was 13.9 Kg and the mean reduction in BMI was 4.8 Kg/m2. Weight loss was greater in male patients. Weight loss was accompanied by an improvement of the diseases associated with obesity, in particular diabetes. CONCLUSIONS: The best indications for BIB were: morbidly obese (BMI >40) and super-obese patients (BMI >50) in preparation for bariatric operations; obese patients with BMI 35-40 with co-morbidity in preparation for bariatric surgery; obese patients with BMI 30-35 with a chronic disease otherwise unresolved; patients with BMI <30 only in a multidisciplinary approach. SN - 0172-6390 UR - https://www.unboundmedicine.com/medline/citation/15025034/Intragastric_balloon:_another_option_for_treatment_of_obesity_and_morbid_obesity_ L2 - https://ClinicalTrials.gov/search/term=15025034 [PUBMED-IDS] DB - PRIME DP - Unbound Medicine ER -